To access the full text documents, please follow this link: http://hdl.handle.net/2445/54925
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Miyake, Makito |
dc.contributor.author | Lawton, Adrienne |
dc.contributor.author | Dai, Yunfeng |
dc.contributor.author | Chang, Myron |
dc.contributor.author | Mengual Brichs, Lourdes |
dc.contributor.author | Alcaraz Asensio, Antonio |
dc.contributor.author | Goodison, Steve |
dc.contributor.author | Rosser, Charles J. |
dc.date | 2014-06-11T09:38:58Z |
dc.date | 2014-06-11T09:38:58Z |
dc.date | 2014-02-13 |
dc.date | 2014-06-11T09:38:59Z |
dc.identifier.citation | 1471-2407 |
dc.identifier.citation | 637784 |
dc.identifier.uri | http://hdl.handle.net/2445/54925 |
dc.format | 7 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | BioMed Central |
dc.relation | Reproducció del document publicat a: http://dx.doi.org/10.1186/1471-2407-14-86 |
dc.relation | BMC Cancer, 2014, vol. 14, num. 1, p. 86 |
dc.relation | http://dx.doi.org/10.1186/1471-2407-14-86 |
dc.rights | cc-by (c) Miyake, M. et al., 2014 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Càncer de bufeta |
dc.subject | Marcadors bioquímics |
dc.subject | Assaigs clínics |
dc.subject | Bladder cancer |
dc.subject | Biochemical markers |
dc.subject | Clinical trials |
dc.title | Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |